JP Patent

JP6541635B2 — Ｐａｒｐ阻害剤としての縮合四環式または縮合五環式ジヒドロジアゼピノカルバゾロン

Assigned to BeOne Medicines Ltd · Expires 2019-07-10 · 7y expired

What this patent protects

Patent listed against Talzenna.

Drugs covered by this patent

Patent Metadata

Patent number
JP6541635B2
Jurisdiction
JP
Classification
—
Expires
2019-07-10
Drug substance claim
No
Drug product claim
No
Assignee
BeOne Medicines Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.